Publications

Patrik Erlmann, Simone Schmid, Florian A Horenkamp, Matthias Geyer, Thomas G Pomorski, and Monilola A Olayioye. DLC1 activation requires lipid interaction through a polybasic region preceding the RhoGAP domain.. Molecular biology of the cell, (20)20:4400--4411, 2009. [PUMA: 2009 izi olayioye] URL

Simone Brandt, Kornelia Ellwanger, Cornelia Beuter-Gunia, Marc Schuster, Angelika Hausser, Ingo Schmitz, and Sandra Beer-Hammer. SLy2 targets the nuclear SAP30/HDAC1 complex. International Journal of Biochemistry and Cell Biology, (42)9:1472--1481, 2010. [PUMA: 2010 hausser izi] URL

Kirstin A. Zettlitz, Julia Seitter, Dafne Müller, and Roland E. Kontermann. Humanization of a mouse monoclonal antibody directed against a cell surface-exposed epitope of membrane-associated heat shock protein 70 (Hsp70). Molecular Biotechnology, (46)3:265--278, 2010. [PUMA: 2010 izi kontermann] URL

Margarita Gerken, Anja Krippner-Heidenreich, Steffen Steinert, Sylvia Willi, Felix Neugart, Andrea Zappe, Jörg Wrachtrup, Carsten Tietz, and Peter Scheurich. Fluorescence correlation spectroscopy reveals topological segregation of the two tumor necrosis factor membrane receptors. Biochimica et Biophysica Acta - Biomembranes, (1798)6:1081--1089, 2010. [PUMA: 2010 izi scheuric] URL

A. Hesse, D. Kosmides, R. E. Kontermann, and D. M. Nettelbeck. Tropism Modification of Adenovirus Vectors by Peptide Ligand Insertion into Various Positions of the Adenovirus Serotype 41 Short-Fiber Knob Domain. Journal of Virology, (81)6:2688--2699, 2007. [PUMA: 2007 izi kontermann] URL

Kornelia Ellwanger, Christine Kienzle, Sylke Lutz, Zheng‑Gen Jin, Maria T. Wiekowski, Klaus Pfizenmaier, and Angelika Hausser. Protein kinase D controls voluntary-running-induced skeletal muscle remodelling. Biochemical Journal, (440)3:327--324, 2011. [PUMA: 2011 hausser izi pfizenmaier] URL

Gerlinde Holeiter, Johanna Heering, Patrik Erlmann, Simone Schmid, Ruth Jähne, and Monilola A. Olayioye. Deleted in liver cancer 1 controls cell migration through a dia1-dependent signaling pathway. Cancer Research, (68)21:8743--8751, 2008. [PUMA: 2008 izi olayioye] URL

Jeannette Gerspach, Klaus Pfizenmaier, and Harald Wajant. Therapeutic Targeting of CD95 and the TRAIL Death Receptors. Recent Patents on Anti-Cancer Drug Discovery, (6)3:294--310, 2011. [PUMA: 2011 izi pfizenmaier] URL

Marcus Branschädel, Andrew Aird, Andrea Zappe, Carsten Tietz, Anja Krippner-Heidenreich, and Peter Scheurich. Dual function of cysteine rich domain (CRD) 1 of TNF receptor type 1: Conformational stabilization of CRD2 and control of receptor responsiveness. Cellular Signalling, (22)3:404--414, 2010. [PUMA: 2010 izi scheuric] URL

Hoon Ha Chang, Weiye Wang, Sook Jhun Bong, Chelsea Wong, Angelika Hausser, Klaus Pfizenmaier, Timothy A. McKinsey, Eric N. Olson, and Zheng Gen Jin. Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis. Journal of Biological Chemistry, (283)21:14590--14599, 2008. [PUMA: 2008 hausser izi pfizenmaier] URL

Sandra Barisić, Anja C. Nagel, Mirita Franz-Wachtel, Boris MacEk, Anette Preiss, Gisela Link, Dieter Maier, and Angelika Hausser. Phosphorylation of ser 402 impedes phosphatase activity of slingshot 1. EMBO Reports, (12)6:527--533, 2011. [PUMA: 2011 hausser izi] URL

Roman Fischer, Olaf Maier, Martin Siegemund, Harald Wajant, Peter Scheurich, and Klaus Pfizenmaier. A TNF receptor 2 selective agonist rescues human neurons from oxidative stress-induced cell death. PLoS ONE, (6)11:e27621, 2011. [PUMA: 2011 izi pfizenmaier] URL

Anna Moosmann, Jessica Blath, Robert Lindner, Egbert Müller, and Heiner Böttinger. Aldehyde PEGylation kinetics: A standard protein versus a pharmaceutically relevant single chain variable fragment. Bioconjugate Chemistry, (22)8:1545--1558, 2011. [PUMA: 2011 boettinger izi] URL

Dafne Müller, Anette Karle, Bettina Meißburger, Ines Höfig, Roland Stork, and Roland E. Kontermann. Improved pharmacokinetics of recombinant bispecific antibody molecules by fusion to human serum albumin. Journal of Biological Chemistry, (282)17:12650--12660, 2007. [PUMA: 2007 izi kontermann mueller] URL

Monilola A. Olayioye, Sandra Barisic, and Angelika Hausser. Multi-level control of actin dynamics by protein kinase D. Cellular Signalling, (25)9:1739--1747, September 2013. [PUMA: 2013 hausser izi olayioye] URL

Nora Hornig, Katharina Reinhardt, Vanessa Kermer, Roland E. Kontermann, and Dafne Müller. Evaluating combinations of costimulatory antibody-ligand fusion proteins for targeted cancer immunotherapy. Cancer Immunology, Immunotherapy, (62)8:1369--1380, August 2013. [PUMA: 2013 izi kontermann] URL

H. Vörsmann, F. Groeber, H. Walles, S. Busch, S. Beissert, H. Walczak, and D. Kulms. Development of a human three-dimensional organotypic skin-melanoma spheroid model for in vitro drug testing. Cell Death and Disease, (4)7:e719--e719, July 2013. [PUMA: 2013 izi kulms] URL

Fabian Richter, Timo Liebig, Eric Guenzi, Andreas Herrmann, Peter Scheurich, Klaus Pfizenmaier, and Roland E. Kontermann. Antagonistic TNF receptor one-specific antibody (ATROSAB): Receptor binding and in vitro bioactivity. In Gernot Zissel (Eds.), PLoS ONE, (8)8:e72156, August 2013. [PUMA: 2013 izi kontermann pfizenmaier] URL

Verena Berger, Fabian Richter, Kirstin Zettlitz, Felix Unverdorben, Peter Scheurich, Andreas Herrmann, Klaus Pfizenmaier, and Roland E. Kontermann. An anti-TNFR1 scFv-HSA fusion protein as selective antagonist of TNF action. Protein Engineering, Design and Selection, (26)10:581--587, October 2013. [PUMA: 2013 izi kontermann pfizenmaier] URL

Olaf Maier, Roman Fischer, Cristina Agresti, and Klaus Pfizenmaier. TNF receptor 2 protects oligodendrocyte progenitor cells against oxidative stress. Biochemical and Biophysical Research Communications, (440)2:336--341, October 2013. [PUMA: 2013 izi pfizenmaier] URL